{"schema_version":"secwatch.filing_event.v1","accession":"0001762303-25-000012","form_type":"8-K","ticker":"RCEL","cik":"0001762303","company_name":"AVITA Medical, Inc.","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.912952+00:00","generated_at":"2026-05-17T18:01:14.406810+00:00","sec_items":["1.01","2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"AVITA Medical Q2 revenue $18.4M (+21% YoY); slashes FY2025 revenue guidance to $76M-$81M, delays profitability to 2026","bullets":["Q2 2025 commercial revenue $18.4M (+21% YoY); net loss $9.9M vs $15.4M prior year.","FY2025 revenue guidance reduced to $76M-$81M (prior $100M-$106M) due to MAC payment backlog affecting RECELL demand.","Fifth amendment to OrbiMed credit agreement: TTM revenue covenants lowered through Q2 2026; 400,000 common shares issued in lieu of cash fee.","Michael Tarnoff appointed to Board of Directors; adds healthcare leadership experience.","Clinical highlight: RECELL reduces hospital stays 36%; CMS NTAP approved for inpatient trauma wounds."],"urls":{"canonical":"https://secwatch.observer/filing/0001762303-25-000012","json":"https://secwatch.observer/filing/0001762303-25-000012.json","markdown":"https://secwatch.observer/filing/0001762303-25-000012.md","text":"https://secwatch.observer/filing/0001762303-25-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1762303/000176230325000012/0001762303-25-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1762303/000176230325000012/rcel-20250807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T18:01:14.406810+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}